Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-28

Clinical Trial Update: Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating whether quantitative EEG markers can predict treatment outcomes in major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED